Natixis Advisors’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.23M | Buy |
18,902
+166
| +0.9% | +$10.8K | ﹤0.01% | 1236 |
|
|
2025
Q1 | $1.25M | Buy |
18,736
+135
| +0.7% | +$9.04K | ﹤0.01% | 1217 |
|
|
2024
Q4 | $1.03M | Buy |
18,601
+417
| +2% | +$23K | ﹤0.01% | 1297 |
|
|
2024
Q3 | $1.09M | Buy |
18,184
+6,545
| +56% | +$391K | ﹤0.01% | 1270 |
|
|
2024
Q2 | $741K | Buy |
+11,639
| New | +$741K | ﹤0.01% | 1341 |
|